Search Results - "Vitek, M.P"
-
1
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Published in Neurobiology of aging (01-07-2007)“…Abstract Thinning and discontinuities within the vascular basement membrane (VBM) are associated with leakage of the plasma protein prothrombin across the…”
Get full text
Journal Article -
2
Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease
Published in Neuroscience (31-03-2009)“…Abstract The neurovascular unit (NVU) comprises cerebral blood vessels and surrounding astrocytes, neurons, perivascular microglia and pericytes. Astrocytes…”
Get full text
Journal Article -
3
Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease
Published in Neuroscience (11-08-2010)“…Abstract A central issue in the pathogenesis of tauopathy is the question of how tau protein dysfunction leads to neurodegeneration. We have previously…”
Get full text
Journal Article -
4
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer’s disease pathology following closed head injury: Evidence of pharmacogenomic interaction
Published in Neuroscience (23-02-2007)“…Abstract Apolipoprotein E (apoE) modifies glial activation and the CNS inflammatory response in an isoform-specific manner. Peptides derived from the…”
Get full text
Journal Article -
5
-
6
Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport
Published in Biochimica et biophysica acta (14-02-2001)“…Previous studies have shown that apolipoprotein E (apoE) plays a role in immune function by modulating tissue redox balance. Using a mouse macrophage cell line…”
Get full text
Journal Article -
7
Effect of FTY720 on the SET–PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
Published in Leukemia (01-09-2014)Get full text
Journal Article -
8
APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer's disease transgenics
Published in Neuro-degenerative diseases (01-01-2012)“…After age, the second largest risk factor for Alzheimer's disease (AD) is apolipoprotein E (APOE) genotype, where APOE4 is associated with lower apoE protein…”
Get more information
Journal Article -
9
Targeting SET/[I.sub.2]PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
Published in Oncogene (02-06-2011)“…The SET oncoprotein participates in cancer progression by affecting multiple cellular processes, inhibiting the tumor suppressor protein phosphatase 2A (PP2A),…”
Get full text
Journal Article -
10
Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity
Published in Oncogene (29-10-2009)“…The chemopreventative effects of dithiolethione compounds are attributed to their activation of antioxidant response elements (AREs) by reacting with the…”
Get full text
Journal Article -
11
APOE genotype affects outcome in a murine model of sepsis : implications for a new treatment strategy
Published in Anaesthesia and intensive care (2009)“…In this study, we assessed whether apolipoprotein E (APOE) polymorphism affects inflammatory responses and mortality in the caecal ligation and puncture model…”
Get full text
Journal Article -
12
Investigation of neuroprotective activity of apolipoprotein E peptide mimetic Cog1410 in transgenic lines of Drosophila melanogaster
Published in Biomeditsinskaia khimiia (01-07-2014)“…The neuroprotective activity of apolipoprotein E (apoE) peptide mimetic Cog1410, containing amino acid sequence of the receptor-binding domain apoE, has been…”
Get more information
Journal Article -
13
The release of Alzheimer's disease beta amyloid peptide is reduced by phorbol treatment
Published in The Journal of biological chemistry (18-03-1994)“…Amyloid precursor protein (APP) is cleaved predominantly within the beta amyloid peptide (BAP) domain to release a non-amyloidogenic amino-terminal PN2…”
Get full text
Journal Article -
14
Expression of the Apolipoprotein E Gene Does Not Affect Motor Recovery After Sensorimotor Cortex Injury in the Mouse
Published in Neuroscience (01-01-2000)“…Motor recovery after unilateral sensorimotor cortex ablation or sham-injury was measured in apolipoprotein E knockout and wild-type mice by testing their…”
Get full text
Journal Article -
15
Release of amino-terminal fragments from amyloid precursor protein reporter and mutated derivatives in cultured cells
Published in The Journal of biological chemistry (15-12-1992)“…Abnormal proteolytic processing of amyloid precursor protein (APP) is thought to be central to the formation and deposition of beta amyloid peptide in…”
Get full text
Journal Article -
16
67 In-situ localization of S182 mRNA in sporadic Alzheimer's disease (AD)
Published in Neurobiology of aging (1996)Get full text
Journal Article -
17
Enzymatic generation of the amino terminus of the beta-amyloid peptide
Published in The Journal of biological chemistry (05-08-1993)“…The major pathological change in Alzheimer's disease is the deposition of 39-42-amino acid beta-amyloid peptide (BAP) in the brain. Since BAP begins at the…”
Get full text
Journal Article -
18
Transcript length heterogeneity at the small heat shock protein genes of Drosophila
Published in Journal of molecular biology (01-01-1985)“…Expression of the small heat shock protein (hsp) genes can be induced in cultured Drosophila cells by high temperature shock and by exposure to physiological…”
Get more information
Journal Article -
19
Stimulation of cytoplasmic actin gene transcription and translation in cultured Drosophila cells by ecdysterone
Published in The Journal of biological chemistry (10-02-1984)“…When cultured Drosophila line S3 cells are incubated in the presence of the steroid hormone, ecdysterone, they flatten, elongate, and become motile. We show…”
Get full text
Journal Article